Location:
GeneRulor Human Whole Exome Capture Kit
Human Whole Exome Capture Kit

The whole exome refers to the collection of all exon regions in the genome. Although this region accounts for only about 1% of the human genome, it contains the core genetic information required for protein synthesis and covers more than 85% of functional pathogenic variants related to individual phenotypes, making it a key target for the study of diseaseassociated variants. Whole exome capture sequencing is a genomic analysis method that uses sequence capture technology to accurately capture and enrich DNA from the exon regions of the whole genome, followed by highthroughput sequencing. Compared with whole genome sequencing, it is more economical, requiring only 45 Gb of sequencing data, with a smaller and more manageable dataset and higher analytical efficiency. The GeneRulor Human Whole Exome Capture Kit offers a variety of product options with comprehensive coverage, enabling accurate detection of SNP/InDel variants and supporting compatible CNV detection. It also features an accurate and efficient standardized analysis pipeline, providing a onestop solution for diverse applications such as genetic variant detection and tumor mechanism research, offering comprehensive support for clinical and scientific research.



  • Product Description
  • Product Information
  • Order Procedure

Human Whole Exome Capture Kit


1.Product Description

The whole exome refers to the collection of all exon regions, which contain the essential information required for protein synthesis and cover most functional variants related to individual phenotypes. Whole-exome capture sequencing is a genomic analysis method that uses sequence capture technology to capture and enrich DNA from the exon regions of the whole genome, followed by high-throughput sequencing.

2.Product Features

2.1 Flexible Selection

Various product combination strategies are available for different research purposes, providing precise support for clinical research and scientific fields.

2.2 Comprehensive Coverage

It covers more clinically relevant gene mutation information and accurately detects all SNPs/InDels, effectively reducing the missing information of clinical variants. Meanwhile, it supports CNV detection for common diseases, deeply dissecting the pathogenesis and supporting tumor-related research anddiscovery.

2.3 Accurate and Efficient Analysis Pipeline

Standardized analysis pipeline combined with personalized analysis: equipped with a brand-new exome and CNV analysis pipeline, providing one-stop service and integrated solutions.

   

References

[1] Tian, R. et al. Risk stratification of cervical lesions using capture sequencing and machine learning method based on HPV and human integrated genomic profiles. Carcinogenesis 40, 1220-1228, doi:10.1093/carcin/bgz094 (2019).